Maltose-binding protein isolated from Escherichia coli induces Toll-like receptor 2-mediated viability in U937 cells

Clinical and Translational Oncology

Volumn 13, Issue 7, 2011, Pages 509-518

  Zhao, Xiaoxia ^a   Ni, Weihua ^a   Zhang, Qingyong ^a   Wang, Fengli ^a   Li, Yingying ^a   Sun, Xiaxia ^a   Liu, Zhonghui ^a   Tai, Guixiang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Adjuvant; MBP; Toll like receptor; U937 cells

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALTOSE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR RELA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN U937; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; INTRACELLULAR SIGNALING; LEUKEMIA CELL LINE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL CYCLE; CELL PROLIFERATION; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM;

BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; JURKAT CELLS; MALTOSE-BINDING PROTEINS; MAP KINASE KINASE 4; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; U937 CELLS;

EID: 82255169608     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0689-7     Document Type: Article

References (47)

1. Boos W, Shuman H (1998) Maltose/maltodextrin system of Escherichia coli: transport, metabolism, and regulation. Microbiol Mol Biol Rev 62:204-229 (Pubitemid 28130801)
2. Medintz IL, Deschamps JR (2006) Maltose-binding protein: a versatile platform for prototyping biosensing. Curr Opin Biotechnol 17:17-27 (Pubitemid 43190753)
3. Monk DJ, Walt DR (2004) Optical fiber-based biosensors. Anal Bioanal Chem 379:931-945 (Pubitemid 40877525)
4. Wolfbeis OS (2008) Fiber-optic chemical sensors and biosensors. Anal Chem 80:4269-4283 (Pubitemid 351858552)
5. Baeumner AJ (2003) Biosensors for environmental pollutants and food contaminants. Anal Bioanal Chem 377:434-445 (Pubitemid 40877867)
6. Riggs P (2000) Expression and purification of recombinant proteins by fusion to maltose-binding protein. Mol Biotechnol 15:51-63 (Pubitemid 30451090)
7. Van Neerven RJ, Sparholt SH, Schou C et al (1998) Preserved epitope-specific T cell activation by recombinant Bet v 1-MBP fusion proteins. Clin Exp Allergy 28:423-433 (Pubitemid 28215764)
8. Rico AI, Giroǹs N, Fresno M et al (2002) The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells. Cell Stress Chaperones 7:339-346 (Pubitemid 36008746)
9. Lee LH, Burg E 3rd, Baqar S et al (1999) Evaluation of a truncated recombinant flagellin subunit vaccine against Campylobacter jejun. Infect Immun 67:5799-5805 (Pubitemid 29508101)
10. Pacifico LG, Fonseca CT, Chiari L et al (2006) Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine. Immunobiology 211:97-104 (Pubitemid 43150111)
11. Choi AH, Basu M, McNeal MM et al (2004) Intranasal administration of an Escherichia coliexpressed codon-optimized rotavirus VP6 protein induces protection in mice. Protein Expr Purif 38:205-216 (Pubitemid 39527259)
12. Simmons M, Murphy GS, Hayes CG et al (2001) Short report: antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine. Am J Trop Med Hyg 65:159-161 (Pubitemid 32744223)
13. Echeverria P, Dran G, Pereda G et al (2001) Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination. Immunol Lett 76:107-110 (Pubitemid 32234386)
14. Fernandez S, Palmer DR, Simmons M et al (2007) Potential role for toll-like receptor 4 in mediating Escherichia coli maltose-binding protein activation of dendritic cells. Infect Immun 75:1359-1363 (Pubitemid 46385829)
15. Li X, Jiang S, Tapping RI (2010) Toll-like receptor signaling in cell proliferation and survival. Cytokine 49:1-9
16. Kawai T, Akira S (2010) The role of patternrecognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373-384
17. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783-801 (Pubitemid 43261452)
18. Rosenberg SA, Yang JC, Restifo NP (2004) Cancer immunotherapy: moving beyond current vaccines. Nat Med 10:909-915 (Pubitemid 39273730)
19. Kanzler H, Barrat FJ, Hessel EM (2007) Therapeutic targeting of innate immunity with Tolllike receptor agonists and antagonists. Nat Med 13:552-559 (Pubitemid 46830615)
20. Celis E (2007) Toll-like receptor ligands energize peptide vaccines through multiple paths. Cancer Res 67:7945-7947 (Pubitemid 47395122)
21. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-995 (Pubitemid 41057715)
22. Hemmi H, Takeuchi O, Kawai T et al (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745 (Pubitemid 32015992)
23. Kaisho T, Akira S (2002) Toll-like receptors as adjuvant receptors. Biochim Biophys Acta 1589:1-13 (Pubitemid 34242898)
24. Huang B, Zhao J, Unkeless JC (2008) TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27:218-224
25. Wolska A, Lech-Maranda E, Robak T (2009) Toll-like receptors and their role in hematologic malignancies. Curr Mol Med 9:324-335
26. Spaner DE, Foley R, Galipea J (2008) Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies. Oncogene 27:208-217
27. Matijevic T, Pavelic J (2010) Toll-like receptors: cost or benefit for cancer? Curr Pharm Des 16:1081-1090
28. Jego G, Bataille R, Geffroy-Luseau A et al (2006) Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors. Leukemia 20:1130-1137 (Pubitemid 43797308)
29. Spaner DE, Shi Y, White D (2006) Immunomodulatory effects of Toll-like receptor-7 activation on chronic lymphocytic leukemia cells. Leukemia 20:286-295 (Pubitemid 43148667)
30. Decker T, Schneller F, Sparwasser T et al (2000) Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 95:999-1006 (Pubitemid 30062724)
31. Decker T, Schneller F, Kronschnabl M et al (2000) Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype. Exp Hematol 28:558-568 (Pubitemid 30254457)
32. Smith KD, Andersen-Nissen E, Hayashi F et al (2003) Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4:1247-1253 (Pubitemid 37540694)
33. Janssens S, Beyaert R (2003) Role of toll-like receptors in pathogen recognition. Clin Microbiol Rev 16:637-646 (Pubitemid 37296552)
34. Kyburz D, Rethage J, Seibl R et al (2003) Bacterial peptidoglycans but not CpG oligodeoxynucle otides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48:642-650 (Pubitemid 36301999)
35. Matsuguchi T, Musikacharoen T, Ogawa T et al (2000) Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 165:5767-5772
36. Medvedev AE, Kopydlowski KM, Vogel SN (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 164:5564-5574 (Pubitemid 30389795)
37. Nomura F, Akashi S, Sakao Y et al (2000) Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164:3476-3479 (Pubitemid 30169796)
38. An H, Xu H, Yu Y et al (2002) Up-regulation of TLR9 gene expression by LPS in mouse macrophages via activation of NF-kB, ERK and p38 MAPK signal pathways. Immunol Lett 81:165-169 (Pubitemid 34310220)
39. Zarember KA, Godowski PJ (2002) Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168:554-561 (Pubitemid 34049553)
40. Begum NA, Ishii K, Kurita-Taniguchi M et al (2004) Mycobacterium bovis BCG cell wallspecific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages. Infect Immun 72: 937-948 (Pubitemid 38166674)
41. Kim GY, Han MG, Song YS et al (2004) Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2-and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NF-kappaB. Bio Pharm Bull 27:1656-1662
42. Uchijima M, Raz E, Carson DA et al (2001) Identification of immunostimulatory DNA-induced genes by suppression subtractive hybridization. Biochem Biophys Res Commun 286: 688-691 (Pubitemid 32912942)
43. Gaundar SS, Bendall LJ (2010) The potential and limitations of p38MAPK as a drug target for the treatment of hematological malignancies. Curr Drug Targets 11:823-833
44. Saulle E, Riccioni R, Coppola S et al (2009) Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation. Br J Haematol 145:399-411
45. Srinivasa SP, Doshi PD (2002) Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways cooperate in mediating cytokine-induced proliferation of a leukemic cell line. Leukemia 16:244-253 (Pubitemid 34145142)
46. Luongo D, Severino L, Bergamo P et al (2006) Interactive effects of fumonisin B1 and alphazearalenol on proliferation and cytokine expression in Jurkat T cells. Toxicol In Vitro 20:1403-1410 (Pubitemid 44537668)
47. Tanaka, S, Akaishi E, Hosaka K et al (2005) Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. Biochem Biophys Res Commun 335:162-167 (Pubitemid 41350776)